Lyme, NH, United States of America

James Geoghegan

USPTO Granted Patents = 8 


Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Mind of James Geoghegan: Pioneering Anti-CD25 Antibodies for Cancer Treatment

Introduction: James Geoghegan, a prominent inventor based in Lyme, NH, has made significant contributions to the field of medical science with a total of eight patents under his name. His work primarily focuses on developing innovative antibody sequences that promise to enhance cancer treatment efficacy.

Latest Patents: Among his latest inventions is a revolutionary antibody, anti-CD25-a-672, which targets human CD25 without interfering with the binding of CD25 to IL-2 or its signaling pathways. This antibody showcases two specific binding epitopes: PHATFKAMA YKEGTM (42-56) and YQCVQGYRALH (150-160) on CD25. Such inventions have vast potential, as these antibodies and their antigen-binding portions can be utilized in pharmaceutical compositions aimed at treating cancer. Another significant patent involves the anti-CD25-a-634 antibody, which similarly binds to human CD25, ensuring the treatment methods remain effective for cancer patients.

Career Highlights: Throughout his career, James Geoghegan has worked with notable companies, including Tusk Therapeutics Ltd. and Cancer Research Technology Limited. These organizations have allowed him to leverage his innovative approaches to advance cancer treatment technologies and therapies, contributing to groundbreaking research and development in the field.

Collaborations: Collaboration has been a key aspect of Geoghegan's career. He has had the pleasure of working alongside esteemed colleagues such as Anne Goubier and Beatriz Goyenechea Corzo. Together, they have shared ideas and expertise that have enriched their research efforts and have driven forward the initiatives aimed at better cancer treatments.

Conclusion: James Geoghegan's work in antibody development represents a vital stride toward improving cancer therapies. With his innovative spirit and collaborative approach, he continues to pave the way for advancements in medical science, ultimately aiming for better outcomes for cancer patients. His contributions not only display his expertise but also underscore the importance of innovation in the fight against one of humanity’s most challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…